IGEX - Indo Global Exchange(s) PTE, Ltd.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0000 (0.00%)
At close: 3:45PM EDT
Stock chart is not supported by your current browser
Previous Close0.0007
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0005 - 0.0007
52 Week Range0.0001 - 0.0020
Avg. Volume48,146,737
Market Cap215,597
Beta (3Y Monthly)-9.52
PE Ratio (TTM)N/A
EPS (TTM)-0.0040
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire

    IGEX Welcomes Martina Leon as New CEO

    On August 16th Martina Leon was appointed CEO of IGEX. Now is the right time for a leadership change and Martina is the right person to guide IGEX/HuLogix through the coming era. Martina has 27 years in the medical management field with 15 years in clinical trials.  Martina has taken previous business from $450k revenue to over $1.3mm in less than a year.  With her clinical trial experience, she has written protocols for current and incoming companion animal trials.


    Indo Global Exchange(s) Pte Ltd Announces Shareholder Update

    CLOVERDALE, CA / ACCESSWIRE / July 8, 2019 / Indo Global Exchange(s) Pte Ltd (IGEX) is pleased to update shareholders on the company’s direction under new management. In May of 2019 Jason Black became Director and CEO of Indo Global. Mr. Black intends to transform the entity into a holding company for the sake of incubating pharmaceutical and nutraceutical assets.

  • We're sorry this is all we were able to find about this topic.